DK610888A - Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse - Google Patents

Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse

Info

Publication number
DK610888A
DK610888A DK610888A DK610888A DK610888A DK 610888 A DK610888 A DK 610888A DK 610888 A DK610888 A DK 610888A DK 610888 A DK610888 A DK 610888A DK 610888 A DK610888 A DK 610888A
Authority
DK
Denmark
Prior art keywords
anf
cdd
arg
ser
preparing
Prior art date
Application number
DK610888A
Other languages
English (en)
Other versions
DK174112B1 (da
DK610888D0 (da
Inventor
Wolf-Georg Forssmann
Jeanette M Alt
Gerhard Becker
Franz Herbst
Original Assignee
Bissendorf Peptide Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de
Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de
Application filed by Bissendorf Peptide Gmbh filed Critical Bissendorf Peptide Gmbh
Publication of DK610888D0 publication Critical patent/DK610888D0/da
Publication of DK610888A publication Critical patent/DK610888A/da
Application granted granted Critical
Publication of DK174112B1 publication Critical patent/DK174112B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK198806108A 1987-03-02 1988-11-02 Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler DK174112B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE19873706731 DE3706731A1 (de) 1987-03-02 1987-03-02 Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE3706731 1987-03-02
DE3717329 1987-05-22
DE19873717329 DE3717329A1 (de) 1987-05-22 1987-05-22 Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3741641 1987-12-09
DE3741641 1987-12-09
EP8800144 1988-02-27
PCT/EP1988/000144 WO1988006596A1 (en) 1987-03-02 1988-02-27 New cardiodilatin fragment, process for preparing same and use thereof

Publications (3)

Publication Number Publication Date
DK610888D0 DK610888D0 (da) 1988-11-02
DK610888A true DK610888A (da) 1988-11-02
DK174112B1 DK174112B1 (da) 2002-06-24

Family

ID=27195544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806108A DK174112B1 (da) 1987-03-02 1988-11-02 Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler

Country Status (7)

Country Link
EP (1) EP0349545B1 (da)
JP (1) JP2819467B2 (da)
AT (1) ATE85345T1 (da)
AU (1) AU614738B2 (da)
DE (1) DE3878231T2 (da)
DK (1) DK174112B1 (da)
WO (1) WO1988006596A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262521A (en) * 1991-06-07 1993-11-16 Sri International Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) * 1992-05-15 1993-11-18 Bissendorf Peptide Gmbh Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
ATE226960T1 (de) * 1994-06-02 2002-11-15 Forssmann Wolf Georg Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE19535445A1 (de) * 1995-09-23 1997-03-27 Boehringer Mannheim Gmbh Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
AU7566396A (en) * 1995-11-16 1997-06-05 Boehringer Mannheim Gmbh Process for the preparation of peptides by way of streptavidin fusion proteins
DE19951471A1 (de) 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de) 2001-04-03 2002-10-10 Abc Armbruster Biochemicals Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
SI2510942T1 (sl) 2005-04-07 2016-01-29 Cardiorentis Ag Uporaba natriuretskega peptida za zdravljenje srčne odpovedi
JP2009532385A (ja) 2006-03-30 2009-09-10 パラティン・テクノロジーズ・インコーポレーテッド 線状ナトリウム利尿ペプチド構築物
US7622440B2 (en) 2006-03-30 2009-11-24 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
WO2009034134A2 (en) 2007-09-11 2009-03-19 Pharis Biotec Gmbh Use of natriuretic peptides for treating angioedema syndromes
EP2631247A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
ES2689193T3 (es) 2013-03-08 2018-11-08 Immundiagnostik Ag La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis
EP3740762A1 (en) 2018-01-17 2020-11-25 Immundiagnostik AG Biomarker predicting coronary artery disease
FR3099056B1 (fr) * 2019-07-26 2022-08-12 Univ Rouen Normandie Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004870A1 (en) * 1984-04-19 1985-11-07 Biotechnology Research Partners, Ltd. Novel atrial natriuretic/vasodilator polypeptides
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

Also Published As

Publication number Publication date
DK174112B1 (da) 2002-06-24
WO1988006596A1 (en) 1988-09-07
EP0349545A1 (en) 1990-01-10
JPH02502636A (ja) 1990-08-23
JP2819467B2 (ja) 1998-10-30
AU614738B2 (en) 1991-09-12
EP0349545B1 (en) 1993-02-03
DE3878231T2 (de) 1993-05-27
AU1348188A (en) 1988-09-26
ATE85345T1 (de) 1993-02-15
DK610888D0 (da) 1988-11-02
DE3878231D1 (de) 1993-03-18

Similar Documents

Publication Publication Date Title
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
GEP20033002B (en) Osteoprotegerin Binding Protein and Receptors
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
CA2080462A1 (en) Therapeutic uses of actin-binding compounds
EP1225225A3 (en) Osteogenic devices
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
JPS6486896A (en) Method for isolating basic protein from protein mixture containing the basic protein
NZ232337A (en) Nonglycosylated tpa fragment (355 or 356 residues)
ES2140390T3 (es) Metodos para la trans-desestabilizacion de proteinas in vivo.
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
GB9219936D0 (en) Vaccines
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DE3683447D1 (de) Verfahren zur herstellung von humanlysozym.
DE69233311D1 (de) Weidelgraspollen-allergen
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
AU3595489A (en) Amblyommin, a new active substance for anticoagulant therapy
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
UA27771C2 (uk) Електролітична комірка (варіанти) та спосіб мічення протеїнів, пептидів і інших органічних молекул
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
EP0780472A3 (en) Stress proteins
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK